Form 13-F position report

SAREPTA THERAPEUTICS INC

Reported by CORBYN INVESTMENT MANAGEMENT INC MD

SRPT 1.25 09/15/27 CUSIP 803607AD2 Manager CIK 0000919538

Reported 10,810,000 shares, down 67,000 (0.6%) from the prior quarter.

Reported value 1.2%; share count -0.6% vs. the prior quarter.

Reduced
% of reported 13F value 3.09% This manager · Q3 2026
Shares 10,810,000 Quarter-end amount reported
Reported value $10,377,153 Fair value at quarter end
Consecutive quarters held 3 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2026-03-31 9953689
2026-06-30 10259165
2026-09-30 10377153

Quarterly position history

How this manager's reported quarter-end position changed over time.

3 quarters
Quarterly reported position history for SAREPTA THERAPEUTICS INC held by CORBYN INVESTMENT MANAGEMENT INC MD.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 10,810,000 -67,000 (-0.6%) 3.09% $10,377,153 2026-10-30
Q2 2026 Added 10,877,000 +46,000 (0.4%) 2.96% $10,259,165 2026-08-06
Q1 2026 New 10,831,000 +10,831,000 (0.0%) 3.32% $9,953,689 2026-04-28

Who else reported the position

23 managers reported SAREPTA THERAPEUTICS INC for Q3 2026.

Managers reporting SAREPTA THERAPEUTICS INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
HIGHBRIDGE CAPITAL MANAGEMENT LLC Unchanged 52,306,000 0 1.12% $50,344,525 13 qtrs
DeepCurrents Investment Group LLC Unchanged 17,245,000 0 0.47% $16,530,776 2 qtrs
D E Shaw & Co Inc Unchanged 16,897,000 0 < 0.01% $16,231,408 6 qtrs
Calamos Advisors LLC Unchanged 15,000 0 0.04% $14,384,550 13 qtrs
BROOKFIELD CORPORATION New 12,115,000 +12,115,000 0.01% $11,660,186 1 qtr
CORBYN INVESTMENT MANAGEMENT INC MD This report Reduced 10,810,000 -67,000 3.09% $10,377,153 3 qtrs
Russell Investments Group Ltd Added 6,036,000 +2,861,000 < 0.01% $5,791,711 2 qtrs
Chicago Capital Management LLC Added 4,265 +1,095 3.72% $4,107,432 2 qtrs
BNP Paribas Asset Management Holding S A Added 3,500,000 +3,475,346 < 0.01% $3,340,469 11 qtrs
FMR LLC Unchanged 0 0 < 0.01% $1,434,178 13 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
October 30, 2026
Filing type
13F-HR
Position type
CONV

Voting authority reported

Sole
10,810,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.